Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471230) titled 'Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism' on March 10.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Biocells Medical

Condition: Parkinsonism or Parkinson's Disease Nos Parkinsonism in Diseases Classified Elsewhere

Intervention: Biological: Intrathecal (IT)

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: November 23, 2026

Target Sample Size: 120 ...